Breaking AI & Tech News Analyzed

Massive Desert Storm Sweeps Across Central Iraq On May 18, 2026, a dense sandstorm engulfed large swaths of Iraq, reducing visibility to a few metres and depositing thick layers of dust in urban and rural areas alike. The storm, driven by strong southerly winds, persisted for several hours, disrupting transport, power supplies, and daily life. Surge in Respiratory Admissions Strains Hospital Capacity Medical centres in Baghdad, Basra, and surrounding provinces reported a sharp rise in patients presenting with coughing, wheezing, and shortness of breath. While exact figures are still being compiled, health officials described the influx as “unprecedented” for a single weather event. Emergency departments saw wait times extend by up to 50%. Hospitals activated contingency plans, reallocating staff to respiratory wards. Pharmacies reported a rapid depletion of inhalers and over‑the‑counter cough remedies. Public Health Risks Amplified by Climate‑Driven Dust Events The sandstorm highlights a broader vulnerability: recurring dust storms in the Middle East are linked to rising temperatures and land‑use changes. Fine particulate matter (PM10) from such storms can exacerbate asthma, chronic obstructive pulmonary disease (COPD), and cardiovascular conditions, especially among children, the elderly, and outdoor workers. World Health Organization guidelines flag dust‑related PM10 spikes as a major air‑quality concern. Previous studies in the region associate dust events with a 10‑15% increase in hospital admissions for respiratory ailments. Preparing for the Next Dust Episode Authorities are urged to strengthen early‑warning systems, stockpile essential medical supplies, and promote public‑awareness campaigns on protective measures such as mask usage and indoor air filtration. Long‑term strategies may include reforestation, sustainable land management, and investment in air‑quality monitoring networks to mitigate the health impact of future sandstorms.

Psychiatrist Mandates AI Scribe Consent for New PatientsDr Hemlata Ranga of the Melbourne Clinic in Richmond will only accept new patients who agree to the use of an AI transcription service (such as Heidi Health AI or Microsoft) for session notes. The requirement is spelled out in a registration form that tells patients they must either consent or be referred elsewhere.AI Transcription Tools Gaining Traction in Australian HealthcareAI‑driven note‑taking is becoming commonplace: the Royal Australian College of General Practitioners reports that two in five GPs already use such scribes. The surge coincides with rising demand for mental‑health services, prompting clinicians to seek efficiency gains.Adoption Rates and Market Reach of AI ScribesUse of AI scribes has doubled in the past 12 months, according to the RACGP.Heidi AI has processed 115 million sessions over the last 18 months.Despite rapid growth, concerns linger about transcription accuracy, especially for non‑male, non‑white, non‑heterosexual, or non‑native English speakers.Implications for Patient Rights and Clinical PracticeCritics argue that making AI consent a condition of care creates a power imbalance. Tom Sulston, head of policy at Digital Rights Watch, warns that patients may self‑censor or be denied care if they refuse data sharing. He stresses that AI tools are currently exempt from Therapeutic Goods Administration regulation because they do not diagnose, leaving a regulatory gap.Regulatory Outlook and Future of AI in Mental Health CareStakeholders are calling for legislation that guarantees a legal right to refuse AI without health repercussions. The Melbourne Clinic notes that its psychiatrists operate independently and disclose AI use, but the broader industry may need clearer standards to protect privacy and ensure equitable care.

The Rediscovery of a Forgotten VisionaryGordon Stevenson, a multifaceted artist who made significant contributions to New York's late-70s no wave scene, is about to experience a posthumous renaissance. Four decades after his death, Stevenson has been largely remembered as merely a footnote in other people's stories. However, this is about to change dramatically with the discovery of a storage unit filled with his lost work, including jewelry, collaborations with mail-art pioneer Ray Johnson, and even clues to the whereabouts of a surviving print of his notorious film, Ecstatic Stigmatic.The Early Life and InfluencesStevenson's story begins not in the gritty streets of New York, but 900 miles south in the small town of Dublin, Georgia. Born into a family of "emotionally repressed stoics," he was a maths prodigy with a taste for Flannery O'Connor, Nietzsche, and Sartre. His intellectual pursuits and unconventional lifestyle created a rift with his parents, who expected him to follow a more traditional path. Offered a maths scholarship at Georgia Tech, Stevenson instead chose the liberal arts campus of Eckerd College in St. Petersburg, Florida, further widening the divide with his family.The New York YearsIn 1977, Stevenson and his partner Mirielle Cervenka relocated to New York, a city that photographer Julia Gorton described as "a nihilistic playground for people with trauma." The city was "very destroyed by the drugs and violence," according to Maripol, a European émigré designer and filmmaker who later worked with Grace Jones and Madonna. "But there was freedom. That the city was bankrupt meant low rents. Creative people could afford to live there," Maripol recalls.The Artistic LegacyStevenson's artistic contributions were multifaceted. He and Cervenka founded the jewelry brand LHOOQ, which "repositioned the jewellery for the punk market" by upcycling vintage trinkets. His "memento mori" series focused on crosses and skulls, anticipating gothic fashion and showcasing a macabre sensibility. In music, he joined Lydia Lunch's Teenage Jesus and the Jerks, a band that was, according to Gorton, "really intense, abrasive, not friendly – just a perfect band." Jim Sclavunos, who later drummed for Sonic Youth and Nick Cave and the Bad Seeds, remembers Stevenson as "a very striking presence, depraved in the right ways." His most ambitious work was the film Ecstatic Stigmatic, a $5,000 production inspired by Catholic mysticism and the Jonestown massacre, which Sclavunos found "surprised by how good it was. A lot of no wave cinema looked juvenile. But Ecstatic Stigmatic was very shadowy, sleazy and sexual."The Impact on Contemporary CultureThe rediscovery of Stevenson's work comes at a time when there is renewed interest in the no wave movement and its influence on contemporary art and music. His story offers insight into the creative ferment of late-70s New York, a time when the city's financial struggles paradoxically created space for artistic experimentation. The letters Stevenson wrote to his parents, which his family has recovered, provide a personal window into this period, chronicling life in the downtown demimonde and his experiences as one of New York's first Aids patients. As his sister Barbara Stevenson notes, "Gordon always belonged in New York," and with this rediscovery, his rightful place in the city's artistic pantheon is finally being secured.

Opening the Silent Corridors of Cork’s AsylumThe Guardian’s latest review spotlights *Said the Dead*, a meticulously researched yet poetically daring study of the Cork Mental Hospital – once Ireland’s longest Gothic building, shuttered in the 1990s and now being turned into apartments. Doireann Ní Ghríofa uses the archive as a portal, giving voice to women whose stories were consigned to dusty casebooks.How Doireann Ní Ghríofa Reconstructed 19th‑Century Patient LivesWorking primarily from the hospital’s massive green casebooks, the author is forced to stop a century before the present to respect confidentiality, so the narrative centers on Victorian and Edwardian voices. She extracts vivid portraits – Bridget, a pregnant emigrant turned back home; Anna Martha, a painter who brandished a gun on magistrates; Dora, a sixteen‑year‑old yearning for death; and Muriel, wife of republican lord mayor Terence MacSwiney. The book also foregrounds Lucia Strangman, the first woman psychiatrist in the British Isles, as a thematic double for the author‑reader.Archive constraint: records stop at a 100‑year distance.Key patients: Bridget, Anna Martha, Dora, Muriel.Medical language: “fairies work on her nerves”, “dull”, “intelligent”.Why Revisiting the Asylum Matters for Irish Memory and Mental‑Health DiscourseThe review argues that the book does more than recount forgotten biographies; it interrogates the ethics of reading and surveillance. By positioning herself as “the Reader”, Ní Ghríofa acknowledges the power imbalance inherent in extracting lives from institutional records, echoing contemporary debates on mental‑health stigma and historical accountability. The work thus becomes a catalyst for broader conversations about how societies remember—and often erase—marginalised voices.What This Revival Signals for Historical Narrative and Public EngagementAs the former asylum is repurposed into luxury flats, *Said the Dead* reminds readers that commercial redevelopment can obscure painful histories. The book’s blend of scholarship and imagination may inspire similar projects that rescue silenced narratives, encouraging museums, publishers, and educators to foreground archival voices before they disappear beneath modern façades.

The Latest Ebola Outbreak A new Ebola outbreak has been confirmed in the Democratic Republic of Congo (DR Congo) and Uganda, sparking fears of a wider spread of the deadly virus. According to reports, the outbreak was detected in the eastern part of DR Congo and has since spread to neighboring Uganda. Ebola Cases Reported in Both Countries Health authorities in both countries have reported cases of Ebola, with DR Congo confirming multiple cases and Uganda reporting at least one case. The World Health Organization (WHO) has been notified and is working closely with local health authorities to contain the outbreak. Health Authorities on High Alert DR Congo's Ministry of Health has activated its Ebola response team. Uganda's health authorities have put in place measures to screen travelers from DR Congo. The WHO has provided technical assistance and support to both countries. The Risk of Further Spread The risk of further spread of the virus is high, given the porous border between DR Congo and Uganda. Health experts have warned that if the outbreak is not contained quickly, it could spread to other parts of the region. Efforts to Contain the Outbreak Contact tracing is underway to identify individuals who may have come into contact with infected patients. Health workers are being deployed to affected areas to provide treatment and support. Public awareness campaigns are being launched to educate communities on the risks of Ebola and how to prevent its spread. The Future Outlook The situation is being closely monitored, and health authorities are working tirelessly to contain the outbreak. However, the risk of further spread remains high, and it is crucial that the international community provides support to affected countries to prevent a wider outbreak.

The CMS Pilot to Reimburse Hemp‑Derived Products The Centers for Medicare and Medicaid Services recently began a pilot that allows certain Medicare and Medicaid beneficiaries to be reimbursed for up to $500 worth of hemp‑derived products each year. The program is designed to test whether these products can lower overall health‑care costs for participants. Key Parameters of the Pilot and the Pending Hemp Ban Definition of hemp follows the 2018 Farm Bill – cannabis containing less than 0.3% delta‑9 THC. The November 12, 2026, hemp ban will make any product with more than 0.4 mg THC federally illegal. If enacted, the ban would criminalize the "vast, vast majority of hemp products, including most non‑intoxicating CBD products," according to Jonathan Miller of the US Hemp Roundtable. Legislative Efforts to Counter the Ban Lawmakers have introduced two bills aimed at either delaying or replacing the ban: Cannabinoid Safety and Regulation Act – re‑introduced by Oregon Senator Ron Wyden, proposing a regulated framework for hemp products. A two‑year delay bill – introduced by Indiana Representative Jim Baird in January. Potential Impact on Patients, Industry, and Legal Landscape If the ban takes effect, patients who rely on full‑spectrum CBD could lose access to the most therapeutically effective formulations. Small producers like Inesa Ponomariovaite of Nesa’s Hemp warn they would have to “perform plant surgery” to strip out prohibited cannabinoids, reducing product efficacy. Quality‑control concerns also surface: a recent Forbes Health investigation found mold, yeast, and fungicide in some CBD products, underscoring the need for federal oversight that the proposed safety act would enable. Legal challenges have already emerged. Advocates sued Health Secretary Robert F. Kennedy Jr. and CMS Administrator Mehmet Oz over the pilot, but the court denied the request to block the program. Outlook: Congressional Gridlock vs. Regulatory Reform Industry insiders remain "cautiously optimistic" that Congress will act before the November deadline, but deep partisan polarization makes passage uncertain. The Trump administration has signaled support for full‑spectrum CBD access, yet no concrete executive action has been announced. Should the ban be delayed or replaced, the CMS pilot could continue to generate data on cost‑saving potential, and the FDA may gain authority to enforce safety standards across the hemp market. Conversely, if the ban proceeds unchanged, the pilot could be forced to limit reimbursements to isolated CBD only, dramatically shrinking its therapeutic scope.

Israeli forces targeted the Remal neighbourhood of Gaza City on May 15, 2026, killing Qassam Brigades commander Izz al‑Din al‑Haddad, his family members and several civilians, a strike Hamas denounced as a treacherous assassination.Israeli Strike Eliminates Qassam Brigades Chief Izz al‑Din al‑HaddadThe strike hit a residential building and a civilian vehicle, killing seven Palestinians including three women and a baby. Hamas condemned the operation as “treacherous and cowardly,” labeling al‑Haddad “one of the architects” of the October 7 attacks. Israeli Prime Minister Benjamin Netanyahu and Defence Minister Israel Katz confirmed the target was al‑Haddad.Casualty Toll and Immediate Aftermath Figures3 Palestinians killed in a civilian‑vehicle strike4 killed in the residential‑building strikeDozens wounded; 13 bodies and 57 injured patients received by Gaza hospitals in the last 24 hoursSince the October cease‑fire, Gaza Health Ministry reports 870 deaths and 2,543 injuriesEscalation Risks and Regional Political RepercussionsThe killing is portrayed by Hamas as a breach of the cease‑fire agreement and an example of “ongoing aggression against innocent civilians.” The statement warned that the “cowardly assassination” will not weaken resistance resolve. The incident also drew reactions from the Palestinian Mujahideen Movement, which vowed continued struggle.Potential Trajectories for Gaza Ceasefire and Israeli OperationsAnalysts anticipate heightened Israeli military activity as it seeks to dismantle senior Hamas leadership, while Hamas may intensify rocket fire or guerrilla attacks in retaliation. International diplomatic pressure could increase, urging both sides to return to cease‑fire talks, but the recent high‑profile killing suggests a further widening of the conflict’s scope.

The Personal Mission Behind the InvestmentReed Jobs, son of Apple co-founder Steve Jobs, is bringing his oncology-focused venture capital fund Yosemite to the UK, seeking investment opportunities in cancer care. The 34-year-old's mission is deeply personal, stemming from witnessing his father's death from a rare form of pancreatic cancer in 2011 at age 56. "I saw my dad have cancer when I was a kid, and unfortunately that happens far too often. And that really motivated me to try to transform outcomes for other people out there," Jobs explains.Yosemite's Healthcare Investment StrategyThe San Francisco-based venture fund, named after the California national park where his parents married, manages over $1 billion in assets and has already invested in approximately 20 healthcare startups. Yosemite focuses on innovative approaches to cancer treatment, including gene therapy, cancer vaccines, radiopharmaceuticals, and artificial intelligence. Notable investments include Tune Therapeutics, Azalea Therapeutics, Chai Discovery, and Sage Care in the US, with several UK companies in their portfolio that haven't been publicly announced.Financial Backing and International PartnershipsYosemite receives investment from LifeArc, a UK not-for-profit group focused on rare diseases that was established in 2000 as part of the UK's Medical Research Council. The fund also has partnerships with Oxford and Cambridge universities, where it has provided philanthropic grants. Additional backing comes from US biotech company Amgen, Massachusetts Institute of Technology, Memorial Sloan Kettering Cancer Center in New York, and billionaire investor John Doerr, following a fundraiser earlier this year.UK's Position in Global Cancer Research"Research here is world class," Jobs states during his visit to London for a life sciences conference hosted by LifeArc. The UK's strong academic institutions and research environment make it an attractive location for healthcare investment. Yosemite's international investment strategy includes the UK, where the fund aims to connect with pharmaceutical partners and academics to advance cancer treatment possibilities.Future Vision for Cancer TreatmentJobs envisions a future where cancer shifts from being an "end-stage disease" to an illness that is diagnosed early, monitored, and treated—similar to advances made with HIV and cardiovascular disease. "Today far too many cancers are either diagnosed incidentally, because there's no good early biomarker, or only diagnosed once they are metastatic and extremely advanced," he notes. The fund is particularly focused on immunotherapy, which Jobs identifies as "one of the areas I think is going to have the most promise for patients in the next couple of decades."

The LeadFalling seriously ill, like falling in love, can happen all of a sudden – although this film is not exactly about either. Ryusuke Hamaguchi's new movie, co-scripted with the Franco-Japanese screenwriter Léa Le Dimna and his first not set entirely in Japan, is a bold and high-minded if rather pedagogic work that spreads itself over three hours. It's tender and sometimes beautifully made, but also contrived and occasionally features some too-good-to-be-true caring characters. Frankly, it's rather precious.The Film's International VisionHamaguchi and Le Dimna have taken as their starting point the nonfiction book "You and I: The Illness Suddenly Get Worse" by Makiko Miyano and Maho Isono, a meditative correspondence between a philosopher and medical professional on the subjects of love and mortality. Hamaguchi has opened this out to create a drama set in Paris and Kyoto, and it's incidentally hard not to suspect that Hamaguchi, like many a celebrated movie director spending so much time on the international festival circuit, has been led to create an uneasy international mixture.Care Home Dynamics and CharactersMarie-Lou (Virginie Efira) is the director of a private care home in Paris called the Garden of Freedom, where they practise a care technique called "humanitude," a time-consuming patient-centred approach that exasperates old-fashioned nurse Sophie (Marie Bunel). It needs more staffing facilities than the home is prepared to provide and, in any case, Marie-Lou has a bad habit of being patronising to those who question her. For all that, there are some lovely scenes with caregivers and patients, and these observant, unfussily compassionate moments are where the film works best.Cross-Cultural ConnectionsMarie-Lou is stressed and overworked, and her life is upended when she encounters an autistic Japanese teen called Tomoki (Kodai Kurosaki) in the street, apparently lost; he is being looked after by his grandfather, Gorô (Kyōzō Nagatsuka), an actor in town performing in an experimental piece about psychiatric care in which Tomoki is encouraged to take part if he feels like it. The show is directed by Mari (Tao Okamoto), and her stylish calm and intelligence entrances Marie-Lou; they are clearly on the verge of an intense friendship and perhaps more, although the film is reticent on this last point.Philosophical Exchanges and Narrative ConcernsMarie-Lou comes to a performance, stays for the Q&A; afterwards and reveals herself to be fluent in Japanese, asking questions of Mari in that language which touch on Mari's very serious illness. Some in the audience rather plaintively – and understandably – call for the conversation to be in French, though this film comes close to being insufferable when Gorô solemnly tells everyone that their exchange was so intimate and meaningful that the audience should be content with simply sensing that.The Film's Strengths and WeaknessesAll of a Sudden works best entirely outside the exotically overwritten, overthought bond between Mari and Marie-Lou. The realist set pieces are very moving, showing us patients with dementia surrounded by their families, and also showing us, often with photos of their younger selves in demanding jobs, how these patients have changed. The film's high concept is a little self conscious.All of a Sudden screened at the Cannes film festival.